Atara Biotherapeutics, Inc. - Common Stock (ATRA)

CUSIP: 046513107

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common Stock
Shares outstanding
8,165,808
Total 13F shares
46,455,501
Share change
+2,842,351
Total reported value
$1,707,224,921
Put/Call ratio
88%
Price per share
$36.75
Number of holders
122
Value change
+$103,228,229
Number of buys
79
Number of sells
37

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
77%
6,254,632
$243,931,000 31 Mar 2018
13F
FMR LLC
13F
Company
76%
6,196,562
$241,666,000 31 Mar 2018
13F
Redmile Group, LLC
13F
Company
52%
4,236,017
$165,205,000 31 Mar 2018
13F
BlackRock Finance, Inc.
13F
Company
35%
2,844,441
$110,934,000 31 Mar 2018
13F
BRIDGER MANAGEMENT, LLC
13F
Company
31%
2,539,223
$99,030,000 31 Mar 2018
13F
MORGAN STANLEY
13F
Company
26%
2,158,870
$84,195,000 31 Mar 2018
13F
STATE STREET CORP
13F
Company
25%
2,008,067
$78,317,000 31 Mar 2018
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
21%
1,692,953
$66,025,000 31 Mar 2018
13F
Camber Capital Management LP
13F
Company
20%
1,616,690
$63,051,000 31 Mar 2018
13F
VANGUARD GROUP INC
13F
Company
19%
1,581,840
$61,693,000 31 Mar 2018
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
18%
1,486,567
$57,976,000 31 Mar 2018
13F
ArrowMark Colorado Holdings LLC
13F
Company
18%
1,435,019
$55,966,000 31 Mar 2018
13F
Artal Group S.A.
13F
Company
15%
1,250,000
$48,750,000 31 Mar 2018
13F
CARILLON TOWER ADVISERS, INC.
13F
Company
16%
1,286,445
$47,469,000 31 Mar 2018
13F
Neuberger Berman Group LLC
13F
Company
13%
1,094,481
$42,685,000 31 Mar 2018
13F
FEDERATED HERMES, INC.
13F
Company
5.8%
476,541
$18,585,000 31 Mar 2018
13F
AMERIPRISE FINANCIAL INC
13F
Company
5.2%
424,349
$16,549,000 31 Mar 2018
13F
NORTHERN TRUST CORP
13F
Company
4.8%
391,436
$15,265,000 31 Mar 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.3%
351,753
$13,718,000 31 Mar 2018
13F
PUTNAM INVESTMENTS LLC
13F
Company
3.6%
297,746
$11,612,000 31 Mar 2018
13F
PointState Capital LP
13F
Company
3.6%
296,995
$11,583,000 31 Mar 2018
13F
DEUTSCHE BANK AG\
13F
Company
3.2%
259,269
$10,109,000 31 Mar 2018
13F
NORGES BANK
13F
Company
2.6%
212,540
$8,289,000 31 Mar 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
2.3%
190,880
$7,445,000 31 Mar 2018
13F
JENNISON ASSOCIATES LLC
13F
Company
2.2%
180,695
$7,047,000 31 Mar 2018
13F
12 West Capital Management LP
13F
Company
2.2%
178,700
$6,969,000 31 Mar 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
2.1%
173,194
$6,755,000 31 Mar 2018
13F
Bank of New York Mellon Corp
13F
Company
2.1%
172,183
$6,715,000 31 Mar 2018
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.7%
142,827
$5,570,000 31 Mar 2018
13F
Assenagon Asset Management S.A.
13F
Company
1.7%
137,236
$5,352,000 31 Mar 2018
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.5%
125,396
$4,890,000 31 Mar 2018
13F
PACIFIC HEIGHTS ASSET MANAGEMENT LLC
13F
Company
1.5%
125,000
$4,875,000 31 Mar 2018
13F
Vident Investment Advisory, LLC
13F
Company
1.4%
117,812
$4,559,000 31 Mar 2018
13F
UBS Group AG
13F
Company
1.3%
102,974
$4,016,000 31 Mar 2018
13F
TIVERTON ASSET MANAGEMENT LLC
13F
Company
1.1%
87,735
$3,422,000 31 Mar 2018
13F
HSBC HOLDINGS PLC
13F
Company
0.99%
80,658
$3,146,000 31 Mar 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.9%
73,832
$2,879,000 31 Mar 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.86%
70,475
$2,749,000 31 Mar 2018
13F
CITIGROUP INC
13F
Company
0.73%
59,568
$2,323,000 31 Mar 2018
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.69%
56,476
$2,203,000 31 Mar 2018
13F
ALPS ADVISORS INC
13F
Company
0.69%
56,172
$2,191,000 31 Mar 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.66%
54,222
$2,115,000 31 Mar 2018
13F
University Of Notre Dame du Lac
13F
Individual
0.65%
53,148
$2,073,000 31 Mar 2018
13F
Swiss National Bank
13F
Company
0.64%
52,600
$2,051,000 31 Mar 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.61%
50,110
$1,954,000 31 Mar 2018
13F
ELLINGTON MANAGEMENT GROUP LLC
13F
Company
0.51%
41,600
$1,622,000 31 Mar 2018
13F
TD ASSET MANAGEMENT INC
13F
Company
0.5%
41,089
$1,602,000 31 Mar 2018
13F
CREDIT SUISSE AG/
13F
Company
0.5%
40,861
$1,593,000 31 Mar 2018
13F
CHARTWELL INVESTMENT PARTNERS, LLC
13F
Company
0.45%
36,867
$1,438,000 31 Mar 2018
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.44%
35,700
$1,392,000 31 Mar 2018
13F

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2018

As of 30 Jun 2018, Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,455,501 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, BlackRock Inc., BRIDGER MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, and Camber Capital Management LP. This page lists 122 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders
113
Q2 2018 holders
122
Holder diff
9
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 Value $ Q2 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.